These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 20627194

  • 1. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
    Yokota T, Shibata N, Ura T, Takahari D, Shitara K, Muro K, Yatabe Y.
    Transl Res; 2010 Aug; 156(2):98-105. PubMed ID: 20627194
    [Abstract] [Full Text] [Related]

  • 2. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
    Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):674-88. PubMed ID: 21398618
    [Abstract] [Full Text] [Related]

  • 3. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
    Teng HW, Huang YC, Lin JK, Chen WS, Lin TC, Jiang JK, Yen CC, Li AF, Wang HW, Chang SC, Lan YT, Lin CC, Wang HS, Yang SH.
    J Surg Oncol; 2012 Aug 01; 106(2):123-9. PubMed ID: 22331825
    [Abstract] [Full Text] [Related]

  • 4. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep 01; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 5. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ, Lee SE, Kang SY, Choi YL.
    Pathol Res Pract; 2011 Dec 15; 207(12):762-8. PubMed ID: 22070922
    [Abstract] [Full Text] [Related]

  • 6. A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes.
    Palmirotta R, Ludovici G, De Marchis ML, Leone B, Formica V, Ettorre GM, Cavaliere F, Della-Morte D, Ferroni P, Roselli M, Guadagni F.
    In Vivo; 2012 Dec 15; 26(4):537-47. PubMed ID: 22773565
    [Abstract] [Full Text] [Related]

  • 7. Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer.
    Kim B, Park SJ, Cheon JH, Kim TI, Kim WH, Hong SP.
    World J Gastroenterol; 2014 Apr 21; 20(15):4370-6. PubMed ID: 24764675
    [Abstract] [Full Text] [Related]

  • 8. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.
    Nakae K, Mitomi H, Saito T, Takahashi M, Morimoto T, Hidaka Y, Sakamoto N, Yao T, Watanabe S.
    World J Gastroenterol; 2012 Oct 21; 18(39):5551-9. PubMed ID: 23112547
    [Abstract] [Full Text] [Related]

  • 9. EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.
    Chiosea S, Shuai Y, Cieply K, Nikiforova MN, Dacic S.
    Hum Pathol; 2010 Aug 21; 41(8):1053-60. PubMed ID: 20381121
    [Abstract] [Full Text] [Related]

  • 10. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Aug 21; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 11. Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases.
    Ates O, Yalcin S.
    Indian J Cancer; 2019 Aug 21; 56(2):176-179. PubMed ID: 31062740
    [Abstract] [Full Text] [Related]

  • 12. KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing.
    Akiyoshi K, Yamada Y, Honma Y, Iwasa S, Kato K, Hamaguchi T, Shimada Y, Taniguchi H, Furuta K.
    Anticancer Res; 2013 May 21; 33(5):2129-34. PubMed ID: 23645765
    [Abstract] [Full Text] [Related]

  • 13. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E, Bianchi P, Destro A, Morenghi E, Malesci A, Santoro A, Laghi L, Roncalli M.
    Cancer; 2013 Jan 15; 119(2):266-76. PubMed ID: 22786759
    [Abstract] [Full Text] [Related]

  • 14. Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer.
    Miles KA, Ganeshan B, Rodriguez-Justo M, Goh VJ, Ziauddin Z, Engledow A, Meagher M, Endozo R, Taylor SA, Halligan S, Ell PJ, Groves AM.
    J Nucl Med; 2014 Mar 15; 55(3):386-91. PubMed ID: 24516257
    [Abstract] [Full Text] [Related]

  • 15. The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.
    Ozen F, Ozdemir S, Zemheri E, Hacimuto G, Silan F, Ozdemir O.
    Genet Test Mol Biomarkers; 2013 Feb 15; 17(2):135-9. PubMed ID: 23297805
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.
    Kobayashi M, Sonobe M, Takahashi T, Yoshizawa A, Ishikawa M, Kikuchi R, Okubo K, Huang CL, Date H.
    Anticancer Res; 2011 Dec 15; 31(12):4619-23. PubMed ID: 22199339
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
    Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert AM, Mauermann O, Izbicki JR, Pantel K, Riethdorf S.
    Clin Chem; 2013 Jan 15; 59(1):252-60. PubMed ID: 23136247
    [Abstract] [Full Text] [Related]

  • 18. Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps.
    Galanopoulos M, Papanikolaou IS, Zografos E, Viazis N, Papatheodoridis G, Karamanolis D, Marinos E, Mantzaris GJ, Gazouli M.
    Anticancer Res; 2017 Feb 15; 37(2):651-657. PubMed ID: 28179313
    [Abstract] [Full Text] [Related]

  • 19. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N, Agell L, Lorenzo M, de Muga S, López-Vilaró L, Murillo R, Mojal S, Serrano S, Lorente JA, Lloreta J, Hernández S.
    Hum Pathol; 2012 Oct 15; 43(10):1573-82. PubMed ID: 22417847
    [Abstract] [Full Text] [Related]

  • 20. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC, 't Hart NA, Methorst N, Knol AJ, Prinsen C, Boers JE.
    Eur J Cancer; 2012 May 15; 48(7):1108-15. PubMed ID: 22446020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.